Loading clinical trials...
Loading clinical trials...
The research purpose is to determine if thymus transplantation with immunosuppression is a safe and effective treatment for complete DiGeorge anomaly. The research includes studies to evaluate whether...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sumitomo Pharma Switzerland GmbH
Collaborators
NCT07284641 · Common Variable Immunodeficiency (CVID), Primary Immune Regulatory Disorder, and more
NCT01220531 · Complete DiGeorge Anomaly, DiGeorge Syndrome, and more
NCT02381457 · 22q11 Deletion Syndrome, DiGeorge Syndrome, and more
NCT02787486 · Down Syndrome, Edwards Syndrome, and more
NCT00105274 · DiGeorge Syndrome, Velocardiofacial Syndrome, and more
Duke University Medical Center
Durham, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions